Correlation Between Tianjin Capital and Neumora Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tianjin Capital and Neumora Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tianjin Capital and Neumora Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tianjin Capital Environmental and Neumora Therapeutics, Common, you can compare the effects of market volatilities on Tianjin Capital and Neumora Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tianjin Capital with a short position of Neumora Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tianjin Capital and Neumora Therapeutics,.

Diversification Opportunities for Tianjin Capital and Neumora Therapeutics,

-0.66
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Tianjin and Neumora is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Tianjin Capital Environmental and Neumora Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neumora Therapeutics, and Tianjin Capital is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tianjin Capital Environmental are associated (or correlated) with Neumora Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neumora Therapeutics, has no effect on the direction of Tianjin Capital i.e., Tianjin Capital and Neumora Therapeutics, go up and down completely randomly.

Pair Corralation between Tianjin Capital and Neumora Therapeutics,

Assuming the 90 days horizon Tianjin Capital Environmental is expected to generate 0.89 times more return on investment than Neumora Therapeutics,. However, Tianjin Capital Environmental is 1.12 times less risky than Neumora Therapeutics,. It trades about 0.06 of its potential returns per unit of risk. Neumora Therapeutics, Common is currently generating about -0.03 per unit of risk. If you would invest  9.93  in Tianjin Capital Environmental on October 9, 2024 and sell it today you would earn a total of  28.07  from holding Tianjin Capital Environmental or generate 282.68% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy66.87%
ValuesDaily Returns

Tianjin Capital Environmental  vs.  Neumora Therapeutics, Common

 Performance 
       Timeline  
Tianjin Capital Envi 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Tianjin Capital Environmental are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak forward indicators, Tianjin Capital may actually be approaching a critical reversion point that can send shares even higher in February 2025.
Neumora Therapeutics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Neumora Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Tianjin Capital and Neumora Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tianjin Capital and Neumora Therapeutics,

The main advantage of trading using opposite Tianjin Capital and Neumora Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tianjin Capital position performs unexpectedly, Neumora Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neumora Therapeutics, will offset losses from the drop in Neumora Therapeutics,'s long position.
The idea behind Tianjin Capital Environmental and Neumora Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon